CNVVF saw its Momentum Indicator move above the 0 level on January 03, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator turned positive. In of the 19 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.374) is normal, around the industry mean (23.424). P/E Ratio (85.470) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (2.386) is also within normal values, averaging (5.667). Dividend Yield (0.023) settles around the average of (0.018) among similar stocks. P/S Ratio (2.614) is also within normal values, averaging (41.167).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNVVF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LSMNX | 14.23 | 0.07 | +0.49% |
Loomis Sayles Small/Mid Cap Growth N | |||
WFPCX | 43.81 | 0.15 | +0.34% |
Allspring Special Mid Cap Value C | |||
FFNIX | 13.06 | 0.04 | +0.31% |
Fidelity Advisor Asset Manager 40% I | |||
PGJQX | 16.68 | 0.04 | +0.24% |
PGIM Jennison Global Infrastructure R6 | |||
BIDVX | 14.20 | N/A | N/A |
BlackRock GA Disciplined Vol Eq Instl |
A.I.dvisor indicates that over the last year, CNVVF has been loosely correlated with FLMNY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CNVVF jumps, then FLMNY could also see price increases.
Ticker / NAME | Correlation To CNVVF | 1D Price Change % | ||
---|---|---|---|---|
CNVVF | 100% | N/A | ||
FLMNY - CNVVF | 36% Loosely correlated | N/A | ||
SAFLY - CNVVF | 32% Poorly correlated | N/A | ||
GKOS - CNVVF | 24% Poorly correlated | -0.08% | ||
EW - CNVVF | 23% Poorly correlated | -0.11% | ||
OFIX - CNVVF | 22% Poorly correlated | +1.12% | ||
More |